SEC Form 4 · accession 0000899243-18-021008
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas B Smith
Officer — Chief Medical Officer
Period of report
Aug 1, 2018
Accepted (ET)
Aug 1, 2018 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1,F2 | $2.93 | Aug 1, 2018 | A | 117,691 | A | — | Aug 1, 2028 | Common Stock | 117,691 | 117,691 | D |
Explanation of responses
- F1The exercise price of the stock options issued to the Reporting Person is the volume-weighted average price of the Company's Common Stock for the 30-day period preceding August 1, 2018.
- F2The stock options were issued to the Reporting Person on August 1, 2018, pursuant to a grant under the Company's Equity Incentive Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) August 1, 2019; (ii) August 1, 2020; and (iii) August 1, 2021.